Weekend reads: Senators ask FDA for more oversight following deaths in China clinical trials

US Senators have called for increased FDA scrutiny of data from clinical trials conducted in China following multiple patient deaths, raising concerns about data transparency and safety in overseas trials used for drug approvals.

This Wire brief sits within Fusion42's coverage of Health, and 5 sources have reported it between 21 Aug 2026 and 3 Sep 2026.